Chromadex (CDXC)
NASDAQ:CDXC

Chromadex (CDXC) Financial Statements

427 Followers

Chromadex Financial Overview

Chromadex's market cap is currently ―. The company's EPS TTM is $-0.047; its P/E ratio is -65.32; Chromadex is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 19.50M$ 20.32M$ 22.56M$ 21.00M$ 17.06M
Gross Profit$ 11.97M$ 12.36M$ 13.52M$ 12.02M$ 10.21M
EBIT$ -1.15M$ -2.32M$ -1.90M$ -1.46M$ -980.00K
EBITDA$ -699.00K$ -1.87M$ -1.46M$ -2.51M$ -531.00K
Net Income Common Stockholders$ -959.00K$ -2.19M$ -1.90M$ -1.43M$ -985.00K
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 0.00$ 0.00$ 23.14M$ 20.44M$ 13.06M
Total Assets$ 47.88M$ 53.17M$ 53.82M$ 54.06M$ 45.66M
Total Debt$ 3.79M$ 3.94M$ 4.09M$ 4.26M$ 4.38M
Net Debt$ 3.79M$ 3.94M$ -19.05M$ -16.18M$ -8.68M
Total Liabilities$ 26.18M$ 26.02M$ 25.75M$ 25.39M$ 24.64M
Stockholders Equity$ 27.31M$ 27.15M$ 28.02M$ 28.67M$ 21.02M
Cash Flow-
Free Cash Flow$ 396.00K$ 3.28M$ 2.79M$ -300.00K$ -3.79M
Operating Cash Flow$ 396.00K$ 3.28M$ 2.79M$ -300.00K$ -3.74M
Investing Cash Flow$ -26.00K$ -5.00K$ -91.00K$ -172.00K$ -52.00K
Financing Cash Flow$ -3.00K$ -10.00K$ -1.00K$ 7.68M$ -18.00K
Currency in USD

Chromadex Earnings and Revenue History

Chromadex Debt to Assets

Chromadex Cash Flow

Chromadex Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis